CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- 4 Open-market buy Chief Executive Officer bought 8,000 shares at $1.23 ($9,839)
- 4 Open-market buy Chief Financial Officer bought 4,098 shares at $1.27 ($5,204)
- 424B3 Offering Prospectus
- 8-K Event Delisting notice
- S-8 Other Securities Offered to Employees in Benefit Plans
- 424B3 Offering Prospectus
- 8-K Event Shareholder vote results
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 8-K Event Executive or director change
Page 10 of 74 · 1,465 filings